Autologous iPSC-derived RPE

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Autologous iPSC-derived RPE
Treatment and conditionWhere it standsTrials
Autologous iPSC-derived RPE for macular degenerationTrial registered, as of 19 Nov 2026 (not yet checked by a person)1